Literature DB >> 26403846

Rational design of a low-affinity peptide for the detection of cystatin C in a fast homogeneous immunoassay.

Kristin Dobslaff1, Kristin Zscharnack1, Thomas Kreisig2, Thole Zuchner1,3.   

Abstract

Immunoassays play an essential role in current research and diagnostics resulting in a variety of detection principles. Thereby, homogeneous assays are often used for a fast signal response as demanded for example in point-of-care diagnostics. These systems often rely on a competitive assay design where the sample analyte and the corresponding dye-labeled substance are competing for binding sites on an antibody present in limited amounts. Due to the similar affinities of the antibody towards the sample analyte and the competitor, both sensitivity and assay time are limited. As a consequence, a competitor with a slightly reduced affinity towards the antibody can potentially overcome these drawbacks. Here, we present the rational design of a low-affinity peptide (donor peptide) as a specific analyte competitor for a FRET-based homogeneous immunoassay for the analysis of the protein cystatin C. Thereby, the strategy of peptide-induced antibody generation was combined with the selective variation of the immunization sequence in order to achieve a lower affinity towards the antibody. We could show that shortened donor peptides improved the resulting quenching efficiency in the immunoassay. In addition, the substitution of small hydrophobic amino acids by those with a higher steric demand appeared to be the most promising strategy providing a fast assay response for cystatin C of only 90 s.

Entities:  

Keywords:  Affinity; Antibody generation; FRET; Homogeneous immunoassays; Peptide design

Mesh:

Substances:

Year:  2015        PMID: 26403846     DOI: 10.1007/s00726-015-2101-3

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  1 in total

1.  Quantitation of estradiol by competitive light-initiated chemiluminescent assay using estriol as competitive antigen.

Authors:  Jiuzhi Li; Liuxu Li; Ying Bian; Yang Yu; Zhonghua Qiang; Yuexiang Zhang; Huiqiang Li
Journal:  J Clin Lab Anal       Date:  2019-08-24       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.